Skip to main content
一致魔芋 logo

一致魔芋 — Investor Relations & Filings

Ticker · 920273 ISIN · CNE100005SP4 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 449 across all filing types
Latest filing 2023-12-05 Governance Information
Country CN China
Listing Beijing Stock Exchange 920273

About 一致魔芋

http://www.easykonjac.com/

Hubei Yizhi Konjac Biotechnology Co., Ltd. specializes in the research, development, and large-scale production of konjac-based ingredients and consumer products. The company’s core portfolio includes konjac flour, purified glucomannan, and dietary fibers utilized as functional additives, stabilizers, and gelling agents. Beyond food applications, it develops specialized konjac derivatives for the cosmetic and pharmaceutical sectors, including biodegradable materials and moisturizing components. The firm maintains an integrated industrial chain encompassing raw material sourcing and advanced deep-processing technologies. Its products are designed to meet global standards for health-oriented applications, focusing on low-calorie, high-fiber solutions for weight management and digestive wellness. Through continuous biotechnological innovation, the company provides versatile raw materials and finished goods to diverse international markets.

Recent filings

Filing Released Lang Actions
独立董事专门会议工作制度
Governance Information Classification · 95% confidence The document is titled as a work system for the Independent Directors' Special Meeting of Hubei Yizhi Konjac Biotechnology Co., Ltd. It details the rules, procedures, and governance related to independent directors' meetings, including meeting rules, voting procedures, and responsibilities. There is no financial data, no mention of financial results, no shareholder voting results, no capital changes, no legal proceedings, or other report types. The document is a governance-related internal regulation or policy document. It fits best under Governance Information (CGR) as it details the company's internal rules and governance practices related to independent directors' meetings.
2023-12-05 Chinese
第三届监事会第八次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board (监事会) of 湖北一致魔芋生物科技股份有限公司 regarding meeting decisions, including proposals to increase business scope, amend the company charter, and change the auditing firm. It includes details about the meeting date, attendance, and voting results. The document does not contain financial statements or detailed financial data but is an announcement of meeting resolutions and decisions. It is not a full annual report, audit report, or financial report. It also does not fit into categories like management changes or dividend announcements. Given the nature of the document as a formal announcement of board meeting resolutions, it best fits the category of Regulatory Filings (RNS), which is a fallback for miscellaneous regulatory announcements that do not fit other categories.
2023-12-05 Chinese
信息披露管理制度
Governance Information Classification · 95% confidence The document is a detailed disclosure of the company's information disclosure management system, including rules and procedures for periodic reports (annual, interim, quarterly), temporary reports, board and shareholder meeting resolutions, transaction disclosures, related party transactions, and other significant events. It references regulatory requirements from the China Securities Regulatory Commission and Beijing Stock Exchange, and outlines the responsibilities of directors, supervisors, and senior management in information disclosure. The document is a comprehensive governance and compliance manual rather than an actual financial report or announcement. It does not contain financial statements, earnings data, or audit opinions. It is not a report publication announcement or a brief notice but a full policy document. Therefore, it fits best under Governance Information (CGR), which covers internal rules, board structure, and governance practices.
2023-12-05 Chinese
拟变更会计师事务所公告
Audit Report / Information Classification · 95% confidence The document is an announcement regarding the proposed change of the company's auditor (accounting firm) for the 2023 fiscal year. It details the new auditor's background, qualifications, independence, audit fees, and the procedures followed for the change, including board and audit committee approvals. There is no actual audit report or financial statements included, nor is this a full annual or interim report. The document is a formal disclosure about the auditor change, which is a regulatory announcement related to audit services but not the audit report itself. Given the content and length (3301 characters), it fits best under Audit Report / Information (AR) as it relates to audit matters but is not a full annual report or certification. The document is not a mere announcement of a report publication (RPA) because it contains substantive information about the auditor change and related details, not just a notice. Therefore, the classification is AR with high confidence. FY 2023
2023-12-05 Chinese
关于调整董事会审计委员会的公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding the adjustment of members of the Board Audit Committee. It discusses changes in board committee membership, references compliance with governance regulations, and explicitly states the appointment and removal of specific board members. There is no financial data, no mention of financial results, no report attached or referenced, and the content focuses solely on board/management changes. Therefore, this fits the category of Board/Management Information (MANG). The document length is short and it is not a report publication announcement or certification. Hence, the classification is MANG with high confidence.
2023-12-05 Chinese
关于使用闲置资金进行现金管理的进展公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement from 湖北一致魔芋生物科技股份有限公司 regarding the use of idle funds for cash management, specifically purchasing financial products such as short-term government bond reverse repurchase agreements and broker wealth management products. It includes information about board approvals, investment amounts, risk controls, and detailed tables of financial product transactions. The document is not a full financial report like an Annual Report (10-K) or Interim Report (IR), nor is it a brief earnings release or a call transcript. It is a regulatory disclosure about financing activities related to cash management and investment of idle funds. The document is lengthy (over 12,000 characters) and contains substantive financial data about the company's cash management activities, not just an announcement of a report. Therefore, it fits best under Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes, including use of idle funds for financial products.
2023-11-30 Chinese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.